Nigeria's war on fake drugs shows progress
Nigeria's National Agency for Food and Drug Administration and Control has issued its first report on the level of counterfeit and substandard drugs in the country, following earlier efforts by the Nigerian Ministry of Health and the World Health Organization, from 1989 to 2005.
Among the findings, the NAFDAC said that counterfeit drug levels had fallen from 41% in 2001 to 16.7% this year. A spokesman for the agency added that it is "very clear that a lot of improvement has been made in this fight."
The study was carried out in the four major pharmaceutical product distribution centers in Nigeria: Kano, Lagos, Onitsha and Jos, with each providing a quarter of the samples. Among the drugs investigated were chlorquine, artesunate, arethemeter, paracetamol, nefedipine retard, ampicillin, cloxacillin and piroxican.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
Free
7 day trial access
- All the news that moves the needle in pharma and biotech
- Exclusive features, podcasts, interviews, data analyses and commentary from our global network of life sciences reporters.
- Receive The Pharma Letter daily news bulletin, free forever.
Become a subscriber
£820
Or £77 per month
- Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
- Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
- Daily roundup of key events in pharma and biotech.
- Monthly in-depth briefings on Boardroom appointments and M&A news.
- Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Today's issue
Company Spotlight
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze